Cardiology Research and Practice suggest that the best cut-oﬀ point of e for the prediction of adverse prognosis may be variable depending on population studied. Further studies are necessary for determining the optimal cut-oﬀ points of e for identifying high-risk patients in various populations. Our ﬁndings suggest that patients with impaired LV re- laxation may need more aggressive treatment of CAD. A recent study has reported that altered LV relaxation assessed by Doppler echocardiography is improved after coronary re- vascularization in patients with ischemic cardiomyopathy [27]. The prognostic impact of improved LV relaxation after coronary revascularization in CAD patients merits future research. References [1] W. J. Paulus, C. Tscho¨pe, J. E. Sanderson et al., “How to diag- nose diastolic heart failure: a consensus statement on the diag- nosis of heart failure with normal left ventricular ejection frac- tion by the Heart Failure and Echocardiography Associations of the European Society of Cardiology,” European Heart Jour- nal, vol. 28, no. 20, pp. 2539–2550, 2007. [2] M. J. Garcia, J. D. Thomas, and A. L. Klein, “New doppler echocardiographic applications for the study of diastolic func- tion,” Journal of the American College of Cardiology, vol. 32, no. 4, pp. 865–875, 1998. [3] K. Yamamoto, Y. Sakata, T. Ohtani, Y. Takeda, and T. Mano, “Heart failure with preserved ejection fraction,” Circulation Journal, vol. 73, no. 3, pp. 404–410, 2009. [4] C. M. Yu, J. E. Sanderson, T. H. Marwick, and J. K. Oh, “Tissue doppler imaging. A new prognosticator for cardiovascular diseases,” Journal of the American College of Cardiology, vol. 49, no. 19, pp. 1903–1914, 2007. [5] G. S. Hillis, J. E. Møller, P. A. Pellikka et al., “Noninvasive estimation of left ventricular ﬁlling pressure by E/e is a pow- erful predictor of survival after acute myocardial infarction,” Journal of the American College of Cardiology, vol. 43, no. 3, pp. 360–367, 2004. [6] A. S. P. Sharp, R. J. Tapp, S. A. M. Thom et al., “Tissue Doppler E/E ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy,” European Heart Journal, vol. 31, no. 6, pp. 747–752, 2010. [7] H. Dokainish, W. A. Zoghbi, N. M. Lakkis et al., “Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure,” Journal of the American College of Cardiology, vol. 45, no. 8, pp. 1223–1226, 2005. [8] M. Wang, G. Yip, C. M. Yu et al., “Independent and incre- mental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function,” Jour- nal of the American College of Cardiology, vol. 45, no. 2, pp. 272–277, 2005. [9] M. Wang, G. W. K. Yip, A. Y. M. Wang et al., “Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy,” Journal of Hypertension, vol. 23, no. 1, pp. 183–191, 2005. [10] H. Okura, T. Kubo, K. Asawa et al., “Elevated E/E predicts prognosis in congestive heart failure patients with preserved systolic function,” Circulation Journal, vol. 73, no. 1, pp. 86– 91, 2009. [11] H. Fukuta, N. Ohte, K. Wakami et al., “Reduced renal function is associated with combined increases in ventricular-systolic 7 stiﬀness and arterial load in patients undergoing cardiac cath- eterization for coronary artery disease,” Heart and Vessels, vol. 26, pp. 10–16, 2010. [12] J. L. Weiss, J. W. Frederiksen, and M. L. Weisfeldt, “Hemody- namic determinants of the time course of fall in canine left ventricular pressure,” Journal of Clinical Investigation, vol. 58, no. 3, pp. 751–760, 1976. [13] C. B. Chapman, O. Baker, J. Reynolds, and F. J. Bonte, “Use of biplane cineﬂuorography for measurement of ventricular vol- ume,” Circulation, vol. 18, no. 6, pp. 1105–1117, 1958. [14] S. F. Nagueh, C. P. Appleton, T. C. Gillebert et al., “Recommen- dations for the evaluation of left ventricular diastolic function by echocardiography,” European Journal of Echocardiography, vol. 10, no. 2, pp. 165–193, 2009. [15] R. M. Lang, M. Bierig, R. B. Devereux et al., “Recommenda- tions for chamber quantiﬁcation,” European Journal of Echo- cardiography, vol. 7, no. 2, pp. 79–108, 2006. [16] H. Y. Liang, S. A. Cauduro, P. A. Pellikka et al., “Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events,” American Journal of Cardiology, vol. 97, no. 6, pp. 866–871, 2006. [17] W. C. Little and E. Braunwald, “Assessment of cardiac func- tion,” in Heart disease: A Text Book of Cardiovascular Medicine, Braunwald, Ed., pp. 421–444, W.B.Saunders, Philadelphia, Pa, USA, 1997. [18] S. F. Nagueh, K. J. Middleton, H. A. Kopelen, W. A. Zoghbi, and M. A. Quin˜ones, “Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and esti- mation of ﬁlling pressures,” Journal of the American College of Cardiology, vol. 30, no. 6, pp. 1527–1533, 1997. [19] W. Grossman and L. P. McLaurin, “Diastolic properties of the left ventricle,” Annals of Internal Medicine, vol. 84, no. 3, pp. 316–326, 1976. [20] L. J. Domalik-Wawrzynski, W. J. Powell, L. Guerrero, and I. Palacios, “Eﬀect of changes in ventricular relaxation on early diastolic coronary blood ﬂow in canine hearts,” Circulation Research, vol. 61, no. 5, pp. 747–756, 1987. [21] T. Masuyama, M. Uematsu, Y. Doi et al., “Abnormal coronary ﬂow dynamics at rest and during tachycardia associated with impaired left ventricular relaxation in humans: implication for tachycardia-induced myocardial ischemia,” Journal of the American College of Cardiology, vol. 24, no. 7, pp. 1625–1632, 1994. [22] K. W. Lee, A. D. Blann, and G. Y. H. Lip, “Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation,” American Heart Journal, vol. 150, no. 4, pp. 756–766, 2005. [23] P. O. Bonetti, L. O. Lerman, and A. Lerman, “Endothelial dys-function: a marker of atherosclerotic risk,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 168–175, 2003. [24] C. Held, P. Hjemdahl, N. Ha˚kan Walle´n et al., “Inﬂammatory and hemostatic markers in relation to cardiovascular prog- nosis in patients with stable angina pectorisResults from the APSIS study,” Atherosclerosis, vol. 148, no. 1, pp. 179–188, 2000. [25] J. K. Ghali, Y. Liao, B. Simmons, A. Castaner, G. Cao, and R. S. Cooper, “The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease,” Annals of Internal Medicine, vol. 117, no. 10, pp. 831–836, 1992.